Narrative review / 2012
Lifestyle changes and statin therapy are key strategies for managing hypercholesterolaemia in children and adolescents to prevent premature atherosclerosis.
This review discusses the identification and treatment of hypercholesterolaemia in children and adolescents to prevent cardiovascular disease. Initial strategies focus on lifestyle interventions such as dietary modifications and increased physical activity. If these measures are inadequate to lower LDL-C levels, pharmacological therapy, particularly statins, should be considered starting from age 8 years. Long-term safety data and ongoing monitoring remain necessary for pediatric patients undergoing lifelong statin treatment.
- Study type
- Narrative review
- Who was studied
- Children and adolescents with hypercholesterolaemia
- What was measured
- Management and drug therapy of childhood hypercholesterolaemia
THE PAPER
Drug therapy of hypercholesterolaemia in children and adolescents.
Braamskamp MJ, Wijburg FA, Wiegman A. Drugs, 2012.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.